IRIS - Res&Arch Institutional Research Information System - Research & Archive

NENCI, Giuseppe Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.623
AS - Asia 2.260
EU - Europa 1.983
SA - Sud America 259
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.553
SG - Singapore 812
HK - Hong Kong 751
UA - Ucraina 487
IE - Irlanda 329
RU - Federazione Russa 291
BR - Brasile 199
CN - Cina 191
VN - Vietnam 178
SE - Svezia 160
DE - Germania 141
IT - Italia 137
FI - Finlandia 132
FR - Francia 121
GB - Regno Unito 84
TR - Turchia 83
KR - Corea 64
CA - Canada 37
IN - India 37
AR - Argentina 26
BD - Bangladesh 21
IQ - Iraq 19
PK - Pakistan 18
JP - Giappone 16
MX - Messico 16
NL - Olanda 16
PL - Polonia 15
ZA - Sudafrica 15
BE - Belgio 14
CH - Svizzera 13
ID - Indonesia 12
UZ - Uzbekistan 11
MY - Malesia 10
CO - Colombia 8
EG - Egitto 8
SA - Arabia Saudita 8
LB - Libano 7
VE - Venezuela 7
GR - Grecia 6
AT - Austria 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
MA - Marocco 5
PY - Paraguay 5
BG - Bulgaria 4
ES - Italia 4
LT - Lituania 4
PH - Filippine 4
AO - Angola 3
BO - Bolivia 3
CL - Cile 3
HN - Honduras 3
HU - Ungheria 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
TN - Tunisia 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
ME - Montenegro 1
MM - Myanmar 1
MR - Mauritania 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 7.172
Salva come PNG Salva come JPEG
Città #
Hong Kong 751
Singapore 548
Chandler 342
Dublin 329
Jacksonville 270
San Mateo 201
San Jose 195
Ashburn 142
Boardman 113
Santa Clara 101
Moscow 99
Dong Ket 88
Medford 84
Princeton 84
Ann Arbor 79
Lauterbourg 75
Altamura 72
Izmir 69
Seoul 64
Wilmington 64
Beijing 51
Des Moines 49
Andover 48
Lawrence 43
Helsinki 36
Munich 33
Ho Chi Minh City 30
Los Angeles 29
The Dalles 29
New York 27
Piscataway 26
Saint Petersburg 23
Shanghai 21
Hanoi 19
Brussels 14
Orem 14
Ottawa 14
Tokyo 14
Frankfurt am Main 13
Norwalk 13
Perugia 13
Denver 12
Montreal 12
São Paulo 12
Woodbridge 12
Dallas 11
Turku 11
London 10
Houston 9
Johannesburg 8
Macerata 8
San Francisco 8
Stockholm 8
Baghdad 7
Brooklyn 7
Council Bluffs 7
Den Haag 7
Toronto 7
Atlanta 6
Auburn Hills 6
Cairo 6
Chennai 6
Da Nang 6
Manchester 6
Phoenix 6
San Paolo di Civitate 6
Amsterdam 5
Belo Horizonte 5
Hải Dương 5
Kuala Lumpur 5
Mumbai 5
Poplar 5
Ankara 4
Charlotte 4
Chicago 4
Dearborn 4
Dhaka 4
Guangzhou 4
Guayaquil 4
Kraków 4
Medellín 4
Mexico City 4
Rio de Janeiro 4
Warsaw 4
Barnet 3
Blumenau 3
Boston 3
Brasília 3
Casablanca 3
Catanduva 3
Chandigarh 3
Concord 3
Curitiba 3
Karachi 3
Karbala 3
La Paz 3
Lahore 3
Mar del Plata 3
New Delhi 3
Ninh Bình 3
Totale 4.659
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 526
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 176
A case of Capnocytophaga canimorsus sepsis and suspected myocardial injury following a dog bite 167
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 149
Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats 122
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 118
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 117
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 108
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 108
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 108
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 107
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 106
Choline plasmalogen biosynthesis by transmethylation in human platelets 105
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 104
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The EVEREST Trial 103
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 101
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 100
Risk factor for upper limb deep vein thrombosis 96
Profilassi della trombosi venosa profonda in neurochirurgia 95
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 95
Effect of different plasma expanders on erythrocyte filterability 95
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 94
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 91
Effect of pentoxifylline on platelet aggregation 91
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 90
Cholinephosphotransferase activity in human platelet 90
Kidney failure and endothelial disfunction: effects of haemodialysis 89
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 89
Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in humans is not mediated by prostaglandins 89
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial 88
Diagnostica generale delle malattie emorragiche. 88
Erythocyte deformability changes in normal pregnancy and preeclampsia 87
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 86
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial 85
Characterization of N, N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. 84
Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin -C treatment 83
Evaluation of the antithrombotic activity of unfractioned heparin or nadroparine after oral administration in man 81
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression 81
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 79
Risk factor for upper extremity deep vein thrombosis 77
Intrinsically defective or exhausted platelets in hairy cell leukemia? 77
Platelets release their lysosomal content in vivo in humans upon activation 76
Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism 75
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 75
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 75
High shear stress induces nitric oxide synthesis in human platelets - 74
Infusion of vincristine-loaded platelets in acute ITP refractory to steroids: an alternative to splenectomy 74
Inhibition of fluid phase and fibrin bound thrombin: effect of heparin, r-hirudin, PEG-rm-hirudin and a thrombin exosite inhibitor 73
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. 73
Human blood platelets release their lysosomal content ''in vivo'' at a localized site of platelet activation 73
Platelet activation and allergic asthma. 73
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 73
Treatment of intermittent claudication with mesoglycan - a placebo-controlled, double - blind study. 72
Erythrocyte deformability in pre-eclamptic women and their newborn in the evaluation of microcirculatory impairment. 72
Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures 72
Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment 71
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement 70
Ultraviolet spectra of membrane-rich human platelet particulates. Normal data and specular abnormalities in hypo- and hyper-betalipoproteinemia 69
Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disorders 67
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 66
Evidence for platelet activation in allergic asthma. 66
Thrombolytic therapy for thromboembolism of vertebrobasilar artery. 64
Thrombolytic therapy for thromboembolism of the vertebrobasilar artery. 64
Red cell deformability alterations in normal late pregnancy: possible role of plasma components 64
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. 63
Vincristine-loaded platelets for autoimmune thrombocytopenic purpura 62
Platelets release lambda-granules (lysosomes) “in vivo” in humans upon activation 61
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic diseases. 59
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets. Role of adenylylcyclase up-regulation 59
Platelet glycohydrolase activities: characterization and release 59
Vinca-loaded platelets 59
Platelets release lambda-granules (lysosomes) in vivo in humans upon activation 58
Liquid Nitrogen Snap Frozen Saphenous Vein for Vascular Access in Dialysis 57
La safena omologa crioconservata come accesso dialitico: valutazione biologica e clinica 57
Interactions between platelets, other cells and eicosanoids in hypertension. 56
Treatment of intermittent claudication with medoglycan- a placebo-controlled, double-blind study 56
Heparin and local haemostasis 55
The reduced erythrocyte deformability in pre-eclampsia is due to altered plasma to red blood cell interactions 54
In vitro and ex vivo effect of indobufen on red blood cell deformability. 53
New pyridazinone derivatives as inhibitors of platelet aggregation. 51
Ruolo del sistema emostatico nella patologia cardiovascolare. Generalità. 51
Thromboxane does not play a significant role in acute, cold induced vasoconstriction in raynaud’s phenomenon 50
Platelets and asthma 49
Human blood platelets release their lysosomal content “in vivo” at a localised site of platelet activation 43
Platelet glycohydrolase activities: Characterization and release 37
Totale 7.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 16 80 97
2021/2022641 9 117 18 27 20 2 6 234 5 16 71 116
2022/20231.149 96 195 26 84 83 140 0 51 417 1 34 22
2023/2024931 30 43 22 4 6 2 645 12 33 17 71 46
2024/20251.054 9 150 24 26 210 30 22 63 222 65 158 75
2025/20261.914 166 100 91 268 279 182 381 70 223 154 0 0
Totale 7.305